Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery

Irén Krassói, J. Pataricza, Ladislaus L. Torday, Attila Kun, J. Papp, Guo Wei He

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. The bradykinin (BK)-induced endothelium-dependent relaxation is impaired in the presence of elevated potassium concentration enhancing the vasospastic tendency of large coronary arteries. Inhibition of the angiotensin-converting enzyme responsible for bradykinin degradation was found to enhance the endothelium-dependent relaxation by BK. The aim of the present study was to investigate the effect of phosphoramidon, known to inhibit a BK-metabolizing neutral endopeptidase enzyme, on relaxation of porcine-isolated coronary artery in depolarizing solution. Methods. Endothelium intact porcine coronary artery rings were studied in organ chambers. The rings were isometrically contracted with potassium chloride (30 mmol/L) and the response to BK (1 to 1,000 nmol/L)-induced relaxation was investigated in the presence of nitric oxide synthase inhibitor N(ω)-nitro-L-arginine (300 μmol/L) alone and in combination with the cyclooxygenase inhibitor indomethacin (10 μmol/L), and that of the inhibitor of calcium-dependent potassium channels tetraethylammonium (7 mmol/L). Under these conditions, phosphoramidon (10 μmol/L), an inhibitor of a neutral endopeptidase enzyme (EC.3.4.24.11.), which is responsible for the degradation of BK, was used to enhance the endothelium-dependent relaxation. Results. Phosphoramidon potentiated the maximum vasorelaxant effect of BK in N(ω)-nitro-L-arginine (control 26.6% ± 10.86% versus phosphoramidon 49.05% ± 4.52%; n = 6, p <0.05) or in N(ω)-nitro-L-arginine + indomethacin-pretreated rings (control 20.7% ± 9.92% versus phosphoramidon 42.0% ± 12.26%; n = 5, p <0.05) and this increased vasodilation was not modified by tetraethylammonium. Conclusions. In the present study phosphoramidon potentiated the effect of BK in the absence of nitric oxide and prostaglandins in porcine-isolated coronary artery. This effect did not depend on tetraethylammonium-sensitive potassium channels. Phosphoramidon may be a useful pharmacologic tool for preserving the vasorelaxing capacity of coronary arteries after cardioplegia. (C) 2000 by The Society of Thoracic Surgeons.

Original languageEnglish
Pages (from-to)878-882
Number of pages5
JournalAnnals of Thoracic Surgery
Volume70
Issue number3
DOIs
Publication statusPublished - 2000

Fingerprint

Bradykinin
Coronary Vessels
Swine
Tetraethylammonium
Endothelium
Arginine
Neprilysin
Indomethacin
Calcium-Activated Potassium Channels
Induced Heart Arrest
Cyclooxygenase Inhibitors
Potassium Chloride
phosphoramidon
Potassium Channels
Peptidyl-Dipeptidase A
Enzymes
Vasodilator Agents
Vasodilation
Nitric Oxide Synthase
Prostaglandins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery. / Krassói, Irén; Pataricza, J.; Torday, Ladislaus L.; Kun, Attila; Papp, J.; He, Guo Wei.

In: Annals of Thoracic Surgery, Vol. 70, No. 3, 2000, p. 878-882.

Research output: Contribution to journalArticle

Krassói, Irén ; Pataricza, J. ; Torday, Ladislaus L. ; Kun, Attila ; Papp, J. ; He, Guo Wei. / Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery. In: Annals of Thoracic Surgery. 2000 ; Vol. 70, No. 3. pp. 878-882.
@article{9cac3a6ca5c34be3b92b1e6b740056b5,
title = "Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery",
abstract = "Background. The bradykinin (BK)-induced endothelium-dependent relaxation is impaired in the presence of elevated potassium concentration enhancing the vasospastic tendency of large coronary arteries. Inhibition of the angiotensin-converting enzyme responsible for bradykinin degradation was found to enhance the endothelium-dependent relaxation by BK. The aim of the present study was to investigate the effect of phosphoramidon, known to inhibit a BK-metabolizing neutral endopeptidase enzyme, on relaxation of porcine-isolated coronary artery in depolarizing solution. Methods. Endothelium intact porcine coronary artery rings were studied in organ chambers. The rings were isometrically contracted with potassium chloride (30 mmol/L) and the response to BK (1 to 1,000 nmol/L)-induced relaxation was investigated in the presence of nitric oxide synthase inhibitor N(ω)-nitro-L-arginine (300 μmol/L) alone and in combination with the cyclooxygenase inhibitor indomethacin (10 μmol/L), and that of the inhibitor of calcium-dependent potassium channels tetraethylammonium (7 mmol/L). Under these conditions, phosphoramidon (10 μmol/L), an inhibitor of a neutral endopeptidase enzyme (EC.3.4.24.11.), which is responsible for the degradation of BK, was used to enhance the endothelium-dependent relaxation. Results. Phosphoramidon potentiated the maximum vasorelaxant effect of BK in N(ω)-nitro-L-arginine (control 26.6{\%} ± 10.86{\%} versus phosphoramidon 49.05{\%} ± 4.52{\%}; n = 6, p <0.05) or in N(ω)-nitro-L-arginine + indomethacin-pretreated rings (control 20.7{\%} ± 9.92{\%} versus phosphoramidon 42.0{\%} ± 12.26{\%}; n = 5, p <0.05) and this increased vasodilation was not modified by tetraethylammonium. Conclusions. In the present study phosphoramidon potentiated the effect of BK in the absence of nitric oxide and prostaglandins in porcine-isolated coronary artery. This effect did not depend on tetraethylammonium-sensitive potassium channels. Phosphoramidon may be a useful pharmacologic tool for preserving the vasorelaxing capacity of coronary arteries after cardioplegia. (C) 2000 by The Society of Thoracic Surgeons.",
author = "Ir{\'e}n Krass{\'o}i and J. Pataricza and Torday, {Ladislaus L.} and Attila Kun and J. Papp and He, {Guo Wei}",
year = "2000",
doi = "10.1016/S0003-4975(00)01632-5",
language = "English",
volume = "70",
pages = "878--882",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Improvement by phosphoramidon of damaged endothelial function in porcine coronary artery

AU - Krassói, Irén

AU - Pataricza, J.

AU - Torday, Ladislaus L.

AU - Kun, Attila

AU - Papp, J.

AU - He, Guo Wei

PY - 2000

Y1 - 2000

N2 - Background. The bradykinin (BK)-induced endothelium-dependent relaxation is impaired in the presence of elevated potassium concentration enhancing the vasospastic tendency of large coronary arteries. Inhibition of the angiotensin-converting enzyme responsible for bradykinin degradation was found to enhance the endothelium-dependent relaxation by BK. The aim of the present study was to investigate the effect of phosphoramidon, known to inhibit a BK-metabolizing neutral endopeptidase enzyme, on relaxation of porcine-isolated coronary artery in depolarizing solution. Methods. Endothelium intact porcine coronary artery rings were studied in organ chambers. The rings were isometrically contracted with potassium chloride (30 mmol/L) and the response to BK (1 to 1,000 nmol/L)-induced relaxation was investigated in the presence of nitric oxide synthase inhibitor N(ω)-nitro-L-arginine (300 μmol/L) alone and in combination with the cyclooxygenase inhibitor indomethacin (10 μmol/L), and that of the inhibitor of calcium-dependent potassium channels tetraethylammonium (7 mmol/L). Under these conditions, phosphoramidon (10 μmol/L), an inhibitor of a neutral endopeptidase enzyme (EC.3.4.24.11.), which is responsible for the degradation of BK, was used to enhance the endothelium-dependent relaxation. Results. Phosphoramidon potentiated the maximum vasorelaxant effect of BK in N(ω)-nitro-L-arginine (control 26.6% ± 10.86% versus phosphoramidon 49.05% ± 4.52%; n = 6, p <0.05) or in N(ω)-nitro-L-arginine + indomethacin-pretreated rings (control 20.7% ± 9.92% versus phosphoramidon 42.0% ± 12.26%; n = 5, p <0.05) and this increased vasodilation was not modified by tetraethylammonium. Conclusions. In the present study phosphoramidon potentiated the effect of BK in the absence of nitric oxide and prostaglandins in porcine-isolated coronary artery. This effect did not depend on tetraethylammonium-sensitive potassium channels. Phosphoramidon may be a useful pharmacologic tool for preserving the vasorelaxing capacity of coronary arteries after cardioplegia. (C) 2000 by The Society of Thoracic Surgeons.

AB - Background. The bradykinin (BK)-induced endothelium-dependent relaxation is impaired in the presence of elevated potassium concentration enhancing the vasospastic tendency of large coronary arteries. Inhibition of the angiotensin-converting enzyme responsible for bradykinin degradation was found to enhance the endothelium-dependent relaxation by BK. The aim of the present study was to investigate the effect of phosphoramidon, known to inhibit a BK-metabolizing neutral endopeptidase enzyme, on relaxation of porcine-isolated coronary artery in depolarizing solution. Methods. Endothelium intact porcine coronary artery rings were studied in organ chambers. The rings were isometrically contracted with potassium chloride (30 mmol/L) and the response to BK (1 to 1,000 nmol/L)-induced relaxation was investigated in the presence of nitric oxide synthase inhibitor N(ω)-nitro-L-arginine (300 μmol/L) alone and in combination with the cyclooxygenase inhibitor indomethacin (10 μmol/L), and that of the inhibitor of calcium-dependent potassium channels tetraethylammonium (7 mmol/L). Under these conditions, phosphoramidon (10 μmol/L), an inhibitor of a neutral endopeptidase enzyme (EC.3.4.24.11.), which is responsible for the degradation of BK, was used to enhance the endothelium-dependent relaxation. Results. Phosphoramidon potentiated the maximum vasorelaxant effect of BK in N(ω)-nitro-L-arginine (control 26.6% ± 10.86% versus phosphoramidon 49.05% ± 4.52%; n = 6, p <0.05) or in N(ω)-nitro-L-arginine + indomethacin-pretreated rings (control 20.7% ± 9.92% versus phosphoramidon 42.0% ± 12.26%; n = 5, p <0.05) and this increased vasodilation was not modified by tetraethylammonium. Conclusions. In the present study phosphoramidon potentiated the effect of BK in the absence of nitric oxide and prostaglandins in porcine-isolated coronary artery. This effect did not depend on tetraethylammonium-sensitive potassium channels. Phosphoramidon may be a useful pharmacologic tool for preserving the vasorelaxing capacity of coronary arteries after cardioplegia. (C) 2000 by The Society of Thoracic Surgeons.

UR - http://www.scopus.com/inward/record.url?scp=0033802373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033802373&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(00)01632-5

DO - 10.1016/S0003-4975(00)01632-5

M3 - Article

C2 - 11016327

AN - SCOPUS:0033802373

VL - 70

SP - 878

EP - 882

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -